U.S. flag An official website of the United States government
  1. Home
  2. Science & Research
  3. Science and Research Special Topics
  4. Advancing Regulatory Science
  5. May 4, 2023: Conversations on Cancer: “Cancer Misinformation: Truth or Consequences” - 05/04/2023
  1. Advancing Regulatory Science

Webcast | Virtual

Event Title
May 4, 2023: Conversations on Cancer: “Cancer Misinformation: Truth or Consequences”
May 4, 2023

May 4, 2023
Registration Info


May 4, 2023


2:00 PM – 3:30 PM Eastern Time


YouTube Live Stream

Organized By:

Oncology Center of Excellence

Twitter: #ConversationsOnCancer 

Sponsored by the U.S. Food & Drug Administration (FDA)

Registration required to attend: https://www.surveymonkey.com/r/GZZMDDJ

The internet is changing the way patients with cancer learn about their disease and their treatment options. Cancer misinformation has become an increasingly prevalent problem, potentially endangering public health and understanding. Rapid evolution of social media platforms on the internet has facilitated the spread of misinformation and given rise to disinformation (intentional misinformation for secondary monetary gain). Unfortunately, there are no clear methods or guidelines to verify the validity of the information shared on mainstream news outlets or what gets posted to social media. 

OCE Conversations on Cancer will bring together experts in medical journalism and the oncology field to give examples of cancer misinformation on social media platforms and in mainstream news outlets. We will discuss how to identify misinformation online, and be able to recognize when information is false or misleading. We’ll discuss strategies for moving forward, barriers and facilitators to social media use for patient and community education.

Webcast Information:

A free-of-charge webcast of this public panel discussion will be provided. Registration for the webcast is required at the link above. 

FDA plans to post archived webcast of this Conversations on Cancer program at: https://www.fda.gov/about-fda/project-community/conversations-cancer

For any inquiries regarding this program, please send an email to: OCE-Engagement@fda.hhs.gov

Back to Top